Woodcock to Congress: U.S. Must Revamp Manufacturing to Spur APIs

CDER Director Janet Woodcock called for an overhaul of American drug manufacturing to offset the nation’s dependence on APIs made in China, India and elsewhere, in Oct. 30 remarks to a House subcommittee.
Source: Drug GMP Report